Clinical Trial: A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Myelofibrosis Due to and Following Polycythemia Vera
Study Type: INTERVENTIONAL
Official Title: A Phase I Study of Ruxolitinib Plus Abemaciclib for Patients With Primary or Post-polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Brief Summary:
The study is being done to see if the combination of ruxolitinib and abemaciclib is a safe and effective treatment for people with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.
Read more